Local Sleep and Alzheimer's Disease Pathophysiology
1Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, United States.
Frontiers in Neuroscience
|October 19, 2020
Summary
Sleep disturbances precede Alzheimer's disease (AD) onset and are linked to increased risk. Local deficits in brain oscillations during sleep correlate with AD pathology and neurodegeneration, offering insights into early disease progression.
Area of Science:
- Neuroscience
- Sleep Medicine
- Gerontology
Background:
- Sleep disturbances are early indicators of Alzheimer's disease (AD) risk.
- Epidemiological studies link various sleep disturbances to mild cognitive impairment (MCI) and earlier AD onset.
- Mechanisms connecting sleep disturbances to AD are emerging from human and animal studies.
Purpose of the Study:
- To review evidence linking local sleep oscillatory deficits to AD pathophysiology.
- To examine the association between specific sleep deficits, AD biomarkers (Aβ and tau), and neurodegeneration.
- To explore the role of fronto-hippocampal and subcortical sleep-wake circuits in AD progression.
Main Methods:
- Review of recent epidemiological and causal manipulation studies.
- Analysis of sleep disturbances in relation to AD biomarkers.
- Examination of brain oscillatory function during sleep (NREM, REM) and its relation to AD pathology.
Main Results:
- Three key sleep oscillatory deficits identified: frontal slow waves (NREM), parietal spindles, and REM sleep desynchrony.
- These deficits differ from normal aging, suggesting an abnormal aging process in AD.
- Local sleep deficits are linked to β-amyloid and tau pathology, and neurodegeneration in vulnerable circuits.
Conclusions:
- Local sleep deficits arise from network-specific dysfunctions driven by regional AD pathology.
- These deficits provide insights into early, circuit-specific AD progression and its impact on brain function.
- Sleep disturbances may contribute to memory decline in AD, highlighting potential for sleep-based interventions.
Keywords:
Alzheimer’s diseaseREM sleepbeta-amyloid proteinneurodegenerationsleepsleep spindleslow wavestau and phospho-tau proteinMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Alzheimer's Disease: Treatment
630
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
630
Sleepwalking and Sleep Talking
553
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
553
Insufficient Sleep and Sleep Deprivation
681
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
681
Understanding Sleep
1.2K
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
1.2K
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K


